Dr. Zbar joined Foresite Capital in 2015 with more than 15 years of healthcare private equity and consulting experience. Prior to joining Foresite, Brett was a partner at Aisling Capital, a life sciences-dedicated venture capital and private equity firm that also manages the investments of the Perseus-Soros Bio Pharmaceutical Fund. Over the course of more than a decade at Aisling Capital, Brett served as a member of the Board of Directors of Aragon Pharmaceuticals, Seragon Pharmaceuticals and Planet Biopharmaceuticals, and as a board observer at Catalent Pharma Solutions, among other companies. Previously, Brett was an associate principal at McKinsey & Company and a senior member of the Pharmaceuticals and Medical Products practice.
Brett received his M.D. from Harvard Medical School and graduated Yale magna cum laude with Distinction in English and Molecular Biophysics & Biochemistry.